Mr Mrs Miss Ms Dr Other

Dr
Mark
Sellick

Senior Patent Attorney

Leeds Office York Office

Electronics

Telephone. +44 1904 732 120
Email. [email protected]

Experience

Mark has particular experience in drafting and prosecution of applications relating to mobile communication devices, standards, and software. He is also part of the MedTech sector group within the Electronics team, looking to engage with clients working in medical and health electronics and software.

Mark did his PhD in the field of nanotechnology, working on electronic control of protein interactions. He has knowledge and laboratory experience in biophysics and electrochemistry, and has particular expertise in combining biological molecules and electronics.

During his undergraduate degree he specialised in quantum physics, with a particular focus on quantum computing.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MPHYS

Theoretical Physics

PHD

Electronic Engineering

Publications

Can AI replace patent attorneys?

View publication online

Can AI replace patent attorneys?

View publication online

Conferences: 2022

December 9th 2022

Health Tech Conference 2022

Attended

Event details

CSR

Mark is a member of HGF’s DEI (Diversity, Equity, and Inclusion) Focus Group, which aims to create a work environment where people can be themselves, achieve their potential, and be recognised for their contribution.

Mark also provides careers advice to university students who are interested in the patent profession through the Leeds Network.

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.